+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Introduction | Crimean Congo Haemorrhagic Fever Virus (CCHF) is a ssRNA virus found in livestock, in ticks parasitising said livestock, and in humans. The pathogen has very low human-to-human transmission; instead it is typically transmitted by tick bites or by consumption of infected meat. Cattle, sheep, and goats may carry the virus but tend not to display symptoms. Symptoms of CCHF infection in humans include haemorrhagic fever, flu-like symptoms, kidney failure, and hepatomegaly; the mortality rate is approximately 30%. There are no specific treatments available for the virus, nor is there a readily-available vaccine. |
Target | Crimean-Congo Hemorrhagic Fever Virus IgG (CCHF-IgG) |
Reactivity | Cow |
Tested Applications | ELISA |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Storage | Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual. |
Validity | The validity for this kit is 6 months. |
Stability | The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout. |
Assay Type | Sandwich |
Assay Data | Qualitative |
Sample Type | Serum and plasma. |
Availability | Shipped within 5-10 working days. |
Note | This product is for research use only. The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments. Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein. |
Plate coated with | Antigen |